The COVID-19 outbreak is now causing widespread disruption in many countries, with increasing impact on supply chains and transport. The European Medicines Agency has announced preparations for an adverse effect on pharmaceutical supply chains into the EU, with a new Executive Steering Group being established.
- What can you do if you or your counterparties are prevented from normal contractual performance by the disease? Douglas McDonald and James Shiel review contractual clauses and principles that may apply in an article here.
- Jog Hundle and Charles Pigott consider the issues for employers here.
- Stephen King, Michael Mitchell and Andrew Tobin review the response of insurers and insureds here.